AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2023
Jun 16, 2023
33298_dirs_2023-06-15_601005ee-57b4-4cfe-8645-a8700c773ce9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2023-06-13
Reporting Person: Roberts Brad Michael (COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-06-13 | Common Stock | A | 150000 | — | Acquired | 247632 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-06-13 | Employee Stock Option (Right to Buy) | $7.5 | D | 200000 | Disposed | Common Stock (200000) | Direct |
Footnotes
F1: The options are being cancelled in exchange for 150,000 restricted shares vesting on January 1, 2024 and performance shares to be reported until settlement. 35,000 of the stock options vested on January 8, 2021, with the remaining stock options scheduled to vest in equal monthly tranches, based on the passage of time, over the following 30 months.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17